We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VCNX market cap is 3.67M. The company's latest EPS is USD -7.7897 and P/E is -0.18.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 20k | 0 | 104k | 232k | 52k |
| Operating Income | -5.83M | -4.99M | -5.07M | -5.72M | -4.55M |
| Net Income | -4.91M | -3.32M | -3.9M | -5.63M | -5.73M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 523k | 625k | 900k | 275k | 570k |
| Operating Income | -32.02M | -28.33M | -22.49M | -19.91M | -22.89M |
| Net Income | -31.86M | -28.85M | -22.38M | -19.82M | -20.25M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.56M | 3.63M | 7.37M | 2.37M | 4.85M |
| Total Liabilities | 6.43M | 5.94M | 4.71M | 5.23M | 6.18M |
| Total Equity | -3.87M | -2.31M | 2.66M | -2.86M | -1.32M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.6M | 11.7M | 9.84M | 7.98M | 3.63M |
| Total Liabilities | 6.88M | 14.31M | 2.43M | 2.78M | 5.94M |
| Total Equity | -2.27M | -2.61M | 7.41M | 5.19M | -2.31M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.64M | -17.23M | -4.63M | -9.05M | -12.25M |
| Investing | -67k | -67k | N/A | -14k | -22k |
| Financing | 7.45M | 12.45M | 6.07M | 7.76M | 13.65M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -30.72M | -28.65M | -25.3M | -19.07M | -17.23M |
| Investing | 14.07M | -290k | -32k | -99k | -67k |
| Financing | 13.8M | 36.76M | 23.32M | 16.98M | 12.45M |
| Market Cap | 3.67M |
| Price to Earnings Ratio | -0.18 |
| Price to Sales Ratio | 6.43 |
| Price to Cash Ratio | 2.39 |
| Price to Book Ratio | -1.59 |
| Dividend Yield | - |
| Shares Outstanding | 2.6M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 45.72k |
| 52 Week Change | -83.43% |
| 52 Week High | 13.02 |
| 52 Week Low | 1.24 |
| Spread (Intraday) | 0.04 (2.78%) |
| Company Name | Vaccinex Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.vaccinex.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
